Fosun International’s Novartis NVS Stock Holding History

Fosun International’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,919	Closed	-$532K	–	328
2018 Q4	$532K	Hold	6,919	–	–	0.03%	213
2018 Q3	$534K	Hold	6,919	–	–	0.03%	181
2018 Q2	$468K	Buy	+6,919	New	+$477K	0.02%	82
2018 Q1	–	Sell	-6,919	Closed	-$521K	–	73
2017 Q4	$521K	Buy	+6,919	New	+$522K	0.05%	56

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fosun International's NVS Position: Q1 2019 in Review

Fosun International sold out of Novartis (NVS) in Q1 2019, closing a stake of 6,919 shares — an estimated $532K sold.

Fosun International first reported a position in NVS in Q4 2017 and held it in 4 quarters. The position peaked at $534K in Q3 2018. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

Fosun International reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
Fosun International sold 6,919 Novartis shares in Q1 2019, an estimated $532K.
Fosun International first reported a position in Novartis in Q4 2017 and held it in 4 quarters.
Fosun International's Novartis position peaked at $534K in Q3 2018.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.